Advancing the analytical toolkit to drive viral gene delivery

Bristol Myers Squibb’s Chelsea Amstuz, Associate Director, Vector Attribute Sciences, and Itzcoatl Pla, Executive Director, Gene Delivery and Editing Process Development, highlight the current state-of-the-art in analytical innovation for gene delivery, including considerations for both viral and non-viral delivery.

Please enter your email to access content Read now